Content area

Abstract

Translate

Health Ever Bio-Tech Co Ltd - Pharmaceuticals and Healthcare Product Pipeline

Summary

Health Ever Bio-Tech Co Ltd (HEB) is a biotechnology company. The company strives to the clinical development of new botanical drug products. Its pipeline products include MCS-2, MSC-5 and MCS-8. HEB’s MCS-2 is being studied in Phase II clinical trials for the treatment of benign prostate hyperplasia and other diseases. HEB researches and develops new botanical drug products for unmet medical needs.

This report provides outline on pipeline products by Number of Pipeline Products by Therapy Area, Indication, development stage and Partnered/Out-Licensed Products.

This report is built using information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Details

1007133
Subject
Health care industry;
Alliances
Business indexing term
Location
North America; Europe; Asia-Pacific region
Company
Health Ever Bio-Tech Co Ltd; Health Ever Bio-Tech Co Ltd
Title
Health Ever Bio-Tech Co Ltd
Publication title
GlobalData Product Pipeline Summaries; London
Number of pages
17
Publication year
2025
Publication date
2025
Publisher
GlobalData plc
Place of publication
London
Country of publication
United Kingdom
Publication subject
Business And Economics
Source type
Report
Language of publication
English
Document type
Company Profile
Document feature
Tables; Graphs; Company description; Company financials; Company competitors; Company SWOT
ProQuest document ID
2454569863
Document URL
https://www.proquest.com/reports/health-ever-bio-tech-co-ltd/docview/2454569863/se-2?accountid=208611
Copyright
Copyright GlobalData plc 2025
Last updated
2025-08-25
Database
ProQuest One Academic